SPDR S&P Pharmaceuticals ETF $XPH Stock Position Reduced by Cetera Investment Advisers

Cetera Investment Advisers lessened its position in shares of SPDR S&P Pharmaceuticals ETF (NYSEARCA:XPH) by 13.1% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 6,629 shares of the company’s stock after selling 1,000 shares during the period. Cetera Investment Advisers owned about 0.18% of SPDR S&P Pharmaceuticals ETF worth $290,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of the company. First Citizens Bank & Trust Co. lifted its holdings in SPDR S&P Pharmaceuticals ETF by 0.6% during the 1st quarter. First Citizens Bank & Trust Co. now owns 128,506 shares of the company’s stock worth $5,629,000 after buying an additional 810 shares during the last quarter. Wells Fargo & Company MN lifted its holdings in SPDR S&P Pharmaceuticals ETF by 24.9% during the 4th quarter. Wells Fargo & Company MN now owns 86,331 shares of the company’s stock worth $3,711,000 after buying an additional 17,234 shares during the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of SPDR S&P Pharmaceuticals ETF by 1,084.8% in the 4th quarter. JPMorgan Chase & Co. now owns 52,640 shares of the company’s stock worth $2,263,000 after purchasing an additional 48,197 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of SPDR S&P Pharmaceuticals ETF in the 4th quarter worth approximately $762,000. Finally, D. E. Shaw & Co. Inc. lifted its holdings in shares of SPDR S&P Pharmaceuticals ETF by 29.0% in the 4th quarter. D. E. Shaw & Co. Inc. now owns 8,437 shares of the company’s stock worth $363,000 after purchasing an additional 1,899 shares during the last quarter.

SPDR S&P Pharmaceuticals ETF Trading Up 0.7%

Shares of NYSEARCA XPH opened at $46.28 on Thursday. The company has a market cap of $166.61 million, a price-to-earnings ratio of 14.28 and a beta of 0.84. SPDR S&P Pharmaceuticals ETF has a 12-month low of $35.22 and a 12-month high of $48.76. The stock’s 50 day simple moving average is $42.42 and its 200 day simple moving average is $41.97.

SPDR S&P Pharmaceuticals ETF Profile

SPDR S&P Pharmaceuticals ETF (the Fund) seeks to replicate as closely as possible the total return performance of the S&P Pharmaceuticals Select Industry Index. The S&P Pharmaceuticals Select Industry Index represents the pharmaceuticals sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.